PTCT

Ptc Therapeutics Stock Analysis

AI Rating

Fair
  • Quality0/10
  • Growth↑ 7/10
  • Value↓ 0/10
Ptc Therapeutics sales and earnings growth
PTCT Growth
Good
  • Revenue Y/Y↓ -53.34%
  • EPS Y/Y↓ -132.80%
  • FCF Y/Y↓ -125.98%
Ptc Therapeutics gross and profit margin trends
PTCT Profitability
Low
  • Gross margin ↑ 92.50%
  • EPS margin↓ -22.60%
  • ROIC 5Y↓ 0.92%
Ptc Therapeutics net debt vs free cash flow
PTCT Risk
Great
  • Debt / Equity↓ 0.0
  • Debt / FCF↓ 0.0
  • Interest coverage↓ -0.4

Ptc Therapeutics stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.

↗ More Biotechnology stocks